GlassScriptPhysician profile
Clayton Lane
NPI 1407078884
$7,445.83
in general payments reported to CMS, 2019-2025
23 companies · $1,975 in 2025
The $1,975 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,937 · 2020: $972 · 2021: $1,386 · 2022: $299 · 2023: $357 · 2024: $518 · 2025: $1,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,561 · Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,561.23 |
| Food and Beverage | $1,289.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $3,847.24 | 2019-2025 | |
| Arthrex, INC. | $1,034.90 | 2025 | |
| Stryker Corporation | $856.07 | 2019-2025 | Mako, Allomatrix, Augment Injectable |
| Smith+Nephew, INC. | $703.94 | 2019-2025 | Lens 4k, Bone Anchors With Arthroscopic Delivery System, Intellio Link Werewolf |
| Zimmer Biomet Holdings, INC. | $258.47 | 2019-2024 | |
| Depuy Synthes Sales INC. | $178.08 | 2019-2023 | Monovisc, Orthovisc |
| Djo, LLC | $102.38 | 2019-2024 | Cmf |
| Vericel Corporation | $66.45 | 2022-2025 | Maci |
| Horizon Therapeutics Plc | $66.11 | 2019-2022 | |
| Heraeus Medical, LLC. | $56.38 | 2021-2022 | |
| Baxter Healthcare | $48.80 | 2019-2022 | |
| Bioventus LLC | $40.30 | 2019 | |
| Avanos Medical | $22.32 | 2021 | |
| Becton, Dickinson and Company | $21.95 | 2024 | Arista Ah Flexitip |
| Trilliant Surgical LLC. | $21.54 | 2023 | 3s Hemi Implant, Large, Non-Sterile |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.41 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.27 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.88 | 2019 | |
| Corcept Therapeutics | $14.60 | 2024 | Korlym |
| Pacira Pharmaceuticals Incorporated | $13.30 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.18 | 2021 | |
| Currax Pharmaceuticals LLC | $12.31 | 2022 | |
| Lilly USA, LLC | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.